Beta-Eudesmol, a sesquiterpenoid alcohol isolated from Atractylodes lancea rhizoma, potentiates the neuromuscular blocking effect of succinylcholine.
This report contains market size and forecasts of Beta-Eudesmol in global, including the following market information:
Global Beta-Eudesmol Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Beta-Eudesmol Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Beta-Eudesmol companies in 2021 (%)
The global Beta-Eudesmol market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Natural Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Beta-Eudesmol include Santa Cruz Biotechnology (SCBT), Merck KGaA (Sigma-Aldrich) and AdooQ, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Beta-Eudesmol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Beta-Eudesmol Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Beta-Eudesmol Market Segment Percentages, by Type, 2021 (%)
Natural Type
Synthetic Type
Global Beta-Eudesmol Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Beta-Eudesmol Market Segment Percentages, by Application, 2021 (%)
Essence
Sanitary Products
Industrial Products
Other
Global Beta-Eudesmol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Beta-Eudesmol Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Beta-Eudesmol revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Beta-Eudesmol revenues share in global market, 2021 (%)
Key companies Beta-Eudesmol sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Beta-Eudesmol sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santa Cruz Biotechnology (SCBT)
Merck KGaA (Sigma-Aldrich)
AdooQ